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Abstract
C-di-GMP, a bacterial second messenger plays a key role in survival and adaptation of bacteria under different
environmental conditions. The level of c-di-GMP is regulated by two opposing activities, namely diguanylate cyclase (DGC)
and phosphodiesterase (PDE-A) exhibited by GGDEF and EAL domain, respectively in the same protein. Previously, we
reported a bifunctional GGDEF–EAL domain protein, MSDGC-1 from Mycobacterium smegmatis showing both these
activities (Kumar and Chatterji, 2008). In this current report, we have identified and characterized the homologous protein
from Mycobacterium tuberculosis (Rv 1354c) named as MtbDGC. MtbDGC is also a bifunctional protein, which can synthesize
and degrade c-di-GMP in vitro. Further we expressed Mtbdgc in M. smegmatis and it was able to complement the MSDGC-1
knock out strain by restoring the long term survival of M. smegmatis. Another protein Rv 1357c, named as MtbPDE, is an EAL
domain protein and degrades c-di-GMP to pGpG in vitro. Rv1354c and 1357c have seven cysteine amino acids in their
sequence, distributed along the full length of the protein. Disulfide bonds play an important role in stabilizing protein
structure and regulating protein function. By proteolytic digestion and mass spectrometric analysis of MtbDGC, connectivity
between cysteine pairs Cys
94-Cys
584, Cys
2-Cys
479 and Cys
429-Cys
614 was determined, whereas the third cysteine (Cys
406) from
N terminal was found to be free in MtbDGC protein, which was further confirmed by alkylation with iodoacetamide labeling.
Bioinformatics modeling investigations also supported the pattern of disulfide connectivity obtained by Mass spectrometric
analysis. Cys
406 was mutated to serine by site directed mutagenesis and the mutant MtbC406S was not found to be active
and was not able to synthesize or degrade c-di-GMP. The disulfide connectivity established here would help further in
understanding the structure – function relationship in MtbDGC.
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Introduction
The cell-cell communication or quorum sensing plays a major
role in survival and maintenance of bacteria during the stationary
phase. One of the interesting aspects of quorum sensing is the
coordinated response of bacteria like biofilm formation, antibiotic
production, sporulation, expression of virulence factor etc. [1]. A
cell produces small autoinducer molecule and simultaneously
senses the concentration of the autoinducer in the cell surface [2].
Second messengers act as autoinducers and relay signals received
at the cell surface to target molecules within the cells. Nucleotide
derivatives, which act as second messengers have been extensively
studied for their regulatory function [3]. Cyclic adenosine
monophosphate (cAMP), Cyclic guanosine monophosphate
(cGMP), Guanosine 39,59 (bis) pyrophosphate (ppGpp) are all
important second messengers both in prokaryotes and eukaryotes.
cGMP is commonly used in eukaryotes but has very little role in
bacteria [4]. cAMP is known to activate catabolite regulatory
protein (CRP), a transcription regulator of gene involved in carbon
metabolism [1,5]. ppGpp on the other hand, regulates bacterial
survival during nutrient starvation [6]. Another nucleotide, Bis-(39-
59)-cyclic dimeric guanosine monophosphate (C-di-GMP) has
been found to be involved in modulating cell surface and biofilm
formation in several bacteria. This molecule was first reported
more than 20 years back as a positive allosteric regulator of
cellulose synthesis [7,8].
C-di-GMP is synthesized from cyclization of two GTP
molecules by diguanylate cyclase (DGC) and degraded to linear
diguanylic acid (pGpG) by phosphodiestrases (PDE) [9,10]. These
two opposing enzymatic activities regulate the cellular pool of c-di-
GMP. The DGC and PDE activity are encoded by conserved
amino acid motifs GGDEF and EAL or HD-GYP, respectively
[3,11,12]. With the advent of whole genome sequencing it is
observed that GGDEF and EAL domain are ubiquitously present
in all bacteria but absent in eukaryote [13]. Gram negative
bacterial genomes harbor large number of proteins belonging to
GGDEF-EAL domain super family, whereas Gram positive
bacteria have small number of them. For example Vibrio cholerae
and Escherichia coli has 53 & 36 proteins but Bacillus subtilis and
Mycobacterium smegmatis has 7 & 1 GGDEF-EAL domain proteins,
respectively [14]. In many cases GGDEF and EAL domains are
present in tandem and most of the proteins so far characterized
have either DGC or PDE-A activity. Interestingly, the possibility
of opposing enzymatic activities co-existing in a single protein has
also been reported [15,16]. Our last report on MSDGC-1 from M.
smegmatis was one such example of a bifunctional protein [17].
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15072C-di-GMP has been implicated in regulation of many cellular
responses relevant to pathogenesis, such as motility, secretion,
cytotoxicityandbiofilmformation.Mostofthestudieshave indicated
that the higher cellular level of c-di-GMP increases the biofilm
formation and promotes the sessile form of life whereas a low level
promotes motility [4,18,19,20]. The appealing aspect of c-di-GMP
signaling is the regulation of virulence gene and the well studied
example is Vibrio cholerae.T h ev i e A ,a nE A Ld o m a i np r o t e i nn o to n l y
controls the host colonization but also regulates the Cholera toxin
production [15]. Similar reports of c-di-GMP mediated expression of
virulence genes and survival in host have been published for
Salmonellatyphimuriumand Pseudomonasaeruginosa[21,22]. Though most
of the studies have been done in Gram negative bacteria, few studies
in Gram positive bacteria indicate that c-di-GMP may not play an
important role in their physiology [23,24]. Contrary to this we have
earlier established the presence and physiological relevance of c-di-
GMP in M. smegmatis, a GC-rich Gram positive bacterium [17]. The
pathogenic species of Mycobacterium genera M. tuberculosis causes
tuberculosis and is one of the oldest diseases known to man. This
work was the initial attempt to characterize the stress elements in M.
tuberculosis and we were interested in following the role of cell-cell
communication in this organism.
Upon sequence alignment (Figure 1) we observed that
MSDGC-1 showed 60% identity at amino acid level to MtbDGC,
suggesting that the protein may have a similar role to play in
Mycobacterium tuberculosis. Fig. 1 shows that three cysteine residues
are conserved in MtbDGC and MSDGC-1, whereas only one
cysteine residue is conserved in all the three proteins. Expression of
MtbDGC in E. coli leads to production of the expressed proteins in
insoluble inclusion bodies. IBs must be resolubilized and refolded
into an active confirmation which requires extensive trial and error
method. In this report we discuss the solubilization of the protein
in its native form maintaining the c-di-GMP synthetic activity.
Disulfide bonds play an important role in stabilizing the native
structure and regulating its basic function [25,26]. Free cysteines
residues are also important to establish protein function, ligand
binding and catalysis [27]. Here we have used chemical and
proteolytic cleavage of MtbDGC and identified the disulfide
linkages by alkylation and Mass spectrometry [28,29]. We
observed that in MtbDGC the disulfide linkages exist between
(Cys
94-Cys
584), (Cys
2-Cys
479) and (Cys
429-Cys
614). The Cys
406 was
found to be free and interestingly when mutated to serine the
protein was found to be inactive. To further understand the
structure and disulfide connectivity of MtbDGC protein, we report
here bioinformatics modeling of MtbDGC protein.
Materials and Methods
Bacterial strains, plasmids and oligonucleotides
Bacterial strains, plasmids and oligonucleotides used in the study
are listed in Table 1. DH5a and BL21 (DE3) E. coli strains were
grown in LB broth at 37uC with agitation or on a plate containing
1.5% w/v agar. Antibiotics were used at following concentration
as and when required: Ampicillin (100 mgm l
21) or kanamycin
(35 mgm l
21) for E. coli and kanamycin (20 mgm l
21)o r
Hygromycin (20 mgm l
21) for M. tuberculosis or M. smegmatis. The
PCR reactions were carried out using Dynazyme EXT polymer-
ase. All of the clones generated were confirmed by sequencing
(MWG, India). Restriction enzymes used for the cloning were
procured from New England Biolabs or Fermentas.
Cloning of MtbDGC and MtbPDE
Genes Rv 1354c (1872bp, 623aa) and Rv 1357c (924bp, 307aa)
were PCR amplified from genomic DNA of M. tuberculosis H37Rv using
a set of primers, MtbRv1354f, MtbRv1354r, MtbRv1357cf and
MtbRv1357cr respectively (Table 1). The amplicons Rv 1354 and Rv
1357c were cloned in pET21b vector using NdeI - XhoI and NdeI -
HindIII restriction sites, respectively. The resultant plasmids were
named as pETMtbDGC for Rv1354c and pETMtbPDE for Rv1357c.
Expression, isolation and purification of MtbDGC and
MtbPDE from inclusion bodies
BL-21 cells carrying MtbDGC and MtbPDE plasmids were
grown at 37uC in 2 L flask containing 500 ml of LB medium
supplemented with 100 mg/ml of ampicillin. Protein expression
was induced when cell density was reached to 0.6 at OD600 with
1 mM of isopropyl-D-thiogalactopyranoside (IPTG). After 4 h
induction, cells were harvested by centrifugation at 8,000 rpm for
15 min at 4uC. Cells were lysed in lysis buffer containing 50 mM
Tris-HCl at pH 7.9, 500 mM NaCl, 100 mM Dithiothreitol
(DTT), 1 mM Ethylenediaminetetraacetic acid (EDTA), 6 M
Urea and 20% Glycerol. Cell suspensions were sonicated at
150 kHz, using a sonicator with a 13 mm probe. This cycle was
repeated three times for a total sonication time of 5 min each. Cell
debris was removed by centrifugation at 12,000 rpm for 20 min at
4uC. After centrifugation the supernatant was loaded on Nickel-
Nitrilotriacetic acid (Ni-NTA) column and washed with 100
column volumes of wash buffer containing 10 mM imidazole. The
protein was eluted with the elution buffer containing 500 mM
imidazole. Eluted protein was further dialyzed as reported below.
Refolding of MtbDGC and MtbPDE proteins with step-
wise dialysis
The protein solubilized in the elution buffer containing 500 mM
imidazole was subsequently dialyzed at various steps with decreasing
concentration of urea in the buffer containing 50 mM Tris-HCl
(pH 7.9 at 4uC), 250 mM NaCl, 10 mM DTT, 5% Glycerol. Urea
concentration was varied from 6 M to 0 M and the dialysate was
allowed to reach equilibrium [30]. As reported earlier disulfide
containing proteins can refold even in the presence of concentrated
denaturant [31]. At the final stage with no urea, precipitation of the
proteinwasnotobserved.Finallytheproteinwasdialysedagainstthe
same buffer having no DTT and assayed for its activity.
Enzymatic assays
Di-guanylate cyclase and phosphodiesterase assays were adapted
from procedures described previously [17,32]. Both the activities
were followed in a buffer containing 5 mM of protein, MtbDGC,
MtbPDE or MSDGC-1 and 25 mM Tris-HCl (pH 7.9), 250 mM
NaCl, 10 mM MgCl2 in 50 ml volume. The reaction was triggered
by the addition of a mixture of 0.1 mM Guanosine 59-triphosphate
(GTP) and a-labeled [
32P]GTP (Board of Radiation and Isotope
Technology(BRIT),India;0.01 mCi ml
21or3500Cimmol
21)inthe
case of MtbDGC. However, MtbPDE activity was checked by
replacing GTP with c-di-GMP. Aliquots were withdrawn at regular
time intervals and the reaction was stopped with an equal volume of
50 mM EDTA. Reaction products (2.5 mL) were separated on
polyethyleneimine-cellulose plates (Merk) in 1:1.5 (v/v) saturated
NH4SO4 and 1.5 M KH2PO4 (pH 3.6) and plates were exposed to
a phosphor-imager screen. The [
32P] c-di-GMP, prepared as
described below was used as substrate for PDE-A activity.
Preparation of [
32P] labelled and nonlablled c-di-GMP was done
by the protocol as described earlier [10].
Western blot analysis
Western blot analysis for the detection of MtbDGC was carried out
with primary antibodies raised in rabbit against the purified protein.
C-di-GMP in Mycobacterium tuberculosis
PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e15072Total cellular proteinsextracted fromcellsgrown at different time were
normalized and 100 mg of the lysate was separated by Poly acrylamide
gel electrophoresis (SDS-PAGE) and blotted on to a Sodium Dodecyl
Sulphate -Polyvinylidende Fluoride (PVDF) membrane. The poly-
clonal serum generated was used as primary antibodies and a
secondary antibody was purchased from Sigma Aldrich. Both were
used after ten thousand fold dilution. The blots were developed with
26 mg aminoethylcarbazole ml
21 and 0.01% v/v H2O2.
Long term starvation cultures
The DMSDGC-1, wild type strain of M. smegmatis mc
2 155 and
strain developed by complementing DMSDGC-1 with Mtbdgc were
grown in MB7H9 with 0.02% w/v glucose and 0.05% v/v
Tween280 till saturation. Cultures were declumped before plating
on agar described earlier [29]. The colony forming units of these
cultures were determined at regular interval of time up to 20 days.
Antibiotics were omitted from the culture to rule out any possible
effect of antibiotics on long term survival.
Proteolytic digestion of protein (MtbDGC)
10 mg of purified full length protein was diluted to final
acetonitrile concentration of 5–10% in presence of digestion buffer
(50 mM of ammonium bicarbonate) and subsequently digested at
37uC overnight using the following proteolytic enzymes in
individual experiments. MtbDGC was digested with 200 ng
trypsin (sequencing grade, modified trypsin (promega)), 200 ng
chymoptrypsin (sequencing grade, modified trypsin (promega))
and double digested with 100 ng of trypsin and 100 ng of
Figure 1. Sequence alignment of MSDGC-1, MtbDGC and MtbEAL was generated by Clustal W and was adjusted manually. Cysteines
at the identical position in both the sequences are indicated by a black background.
doi:10.1371/journal.pone.0015072.g001
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were desalted using C-18 column (Supelco) and subsequently
analyzed by Matrix-Assisted Laser Desorption Ionization Mass
Spectrometry (MALDI MS) and (Liquid Chromatography-Elec-
trospray Ionisation) LC-ESI-MS/MS.
Reduction and alkylation of digested protein sample
10 mL of purified protein was taken in 15 mL of 0.1 M
ammonium bicarbonate buffer pH 8.0 for alkylation. For the
reduction, DTT was added to a final concentration of 8 mM and
was incubated at 37uC for 3 h. For alkylation iodoacetamide (IAM)
was added to the final concentration of 40 mM. The mixture was
incubated at room temperature in the dark for 90 mins. Reaction
mixture was incubated at 37uC overnight for further digestion. Two
sets ofreactionswerecarried out, oneto check foralkylationand the
others for reduction and followed by alkylation.
MALDI-TOF Mass spectrometry
Mass-spectra of digested gel spots were obtained by Matrix-
Assisted Laser Desorption Ionization time of flight (MALDI-TOF)
mass spectrometry on an Ultraflex TOF/TOF spectrometer
(Bruker Daltonics). All the mass spectra were acquired in
positive-ionization mode with reflectron optics. The instrument
was equipped with 50 Hz pulsed nitrogen laser (l=337 nm) and
operated under delayed extraction conditions; delayed time 90-ns,
and 25 kV accelerating voltage. All peptides samples were
prepared by mixing an equal amount of matrices dihydroxybe-
nozic acid/a-cyano-4-hydroxycinnamic acid saturated in 0.1%
Trifluoroacetic acid and acetonitrile (1:1). Typically, 50–100 laser
shots were used to record each spectrum.
Tandem Mass Spectrometry (LC-ESI-MS, MS/MS)
For all the disulfide connectivity studies, the proteolytic peptide
mixture was analyzed by reverse-phase HPLC-ESI-MS, MS/MS
(Electrospray Ionisation, ESI, Bruker Daltonics) spectrometry.
Peptides were separated on HPLC (1100 series HPLC (Agilent))
system equipped with C18 column (Supelco). The column eluant
was directly coupled to a HCT Ultra PTM Discovery System
(ETD II- Bruker Daltonics). Mass spectra (ESI-MS) and tandem
mass spectra (ESI-MS/MS) mode were recorded in positive-ion
mode with a resolution of 12,000-15,000 Full Width of Half
Maximum (FWHM). For tandem mass spectrometry dissociation,
the mass analyzer was set to 61 m/z. The precursor ions were
fragmented in a collision cell using nitrogen as the collision gas.
Spectra were calibrated in static mode using MS/MS fragment
ions of standard supplied by the manufacturer. The enzymatically
digested peptides were separated using mobile phase A consisted of
0.05% formic acid in 98% H2O/2% CAN (Acetonitrile) and B
consisted of 0.05% formic acid in 98% ACN/2% H2O with a
gradient of 5% B in first 5 mins, followed by 95% B in next
50 mins and 5% B in last 10 mins. The gradient times were varied
depending upon the sample specifications.
Homology modeling, minimization and model validation
The sequence and domain information of 623 amino acid
length Rv1354c was taken from swissprot (ID:P64826; http://us.
expasy.org/sprot/) [33]. Protein consists of three domains named
as GAF (residue 28-171), GGDEF (residue 212–345) and EAL
(residue 354–609). Since no homology was found for the full length
protein, Modeling of individual domain was done and joined to
give the complete structure. BLAST [34] and PSI-BLAST [35]
was used against National centre for biotechnology information
(NCBI), Protein Data Bandk (PDB) database to find top hit as a
template and target vs template sequence alignment for individual
domains was done using CLUSTALW2 [36]. On the basis of
sequential similarity 10 models each of EAL and GGDEF domain
were modeled with the protein PDB [37] entry 2R6O (chain:A;i-
dentity:40%) and PDB entry 1W25 (chain:A;identity:40%) respec-
tively using MODELLER release 9v7 [38] and model using
PHYRE [39] server. GAF and EAL domain consists of N terminal
(residue 1–27) and C terminal (residue 610–623) of full protein
respectively. Considering three modeled domains as template full
with the minimum DOPE score was selected. A threaded model of
GAF domain was produced convergence to machine precision.
Minimized structure was validated with the programs PRO-
CHECK score (91.8%) [40], VERIFY3D (78.04%) [41] and
PROSA score (26.68) [42]. PyMOL [43] was used for 3D-
Table 1. Bacterial strains plasmids and primers used in this study.
Strain, plasmid and primer Characteristics Source or Reference
Bacterial strains
DMSDGC-1 M. smegmatis where MSDGC_2196 has been replaced with Kan cassette Kan
r (Kumar et al., 2008)
MtbRv1354 complimented DMSDGC complemented with MtbDGC Kan
r and Hyg
r This work
pET MtbDGC MtbRv1354c cloned in pET 21b Amp
r This work
pET MtbPDE MtbRv1357c cloned in pET 21b Amp
r This work
Plasmids
pET21b Cloning vector (c-terminal His tagged) Amp
r Novagen
pMV361 Cloning vector with hsp60 promoter, kan
r (Stover et al., 1991)
Primers Sequence (59-39)
MtbRv1354f AGCATCCCATATGTGCAACGACACCGCGAC
MtbRv1354r GCACCTCTCGAGAGATAACGCCGGGTCAG
MtbRv1357f ATGCAGCCCTCATATGGATCGTTGTTG
MtbRv1357r CACGCAAGCTTCTCTCTGAAAAAGTCG
MtbC406F CTGCTGGCACCGGGCTCCTTCATCCCTGTG
MtbC406R CACAGGGATGAAGGAGCCCGGTGCCAGCAG
doi:10.1371/journal.pone.0015072.t001
C-di-GMP in Mycobacterium tuberculosis
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9v7. Top scored model was solvated in SPC216 water box (total
number of water molecule: 93396) and charge neutralization was
accomplished with the addition of 7 Na+. Energy minimization of
the model was carried out by GROMACS 3.3.1(The Gronian
Machine for Chemical Simulations) [44] using OPLS [45] force
field and steepest descent method. The minimization was set to
run for 10000 steps with 0.002 ps time step or until.
Alignment of proteins containing GAF, GGDEF, EAL
architecture
Since the protein of interest was having three domains namely
GAF, GGDEF, & EAL domain, protein sequences with the above
architecture were searched in PFAM database [46]. A total of 183
sequences were found. Many of the protein sequences consisted of
transmembrane or low complexity regions and there was a large
variation in length among the sequences. This variation was more
prominent in the region before GAF domain and the relative
positioning of each domain with respect to other. Linker region
between the GAF and GGDEF domain also varied in length. Each
domain was separated from the corresponding sequences by taking
the domain information given in the PFAM database as SWIS-
SPROT did not provide the domain start & end information for all
183sequences.Alignmentofeachofthedomainsequenceswasdone
separately using ClustalW2. Although there was ambiguity in the
assignment of start and end positions of each domain of proteins in
PFAM and SWISSPROT databases, the SWISSPROT data was
considered for modelling as itissupported byexperimental methods.
Cysteine mutation using site directed mutagenesis
Third cysteine of MtbDGC at position 406 was mutated to
serine amino acid using PCR based approaches. In this method
two complimentary oligonucleotides containing the desired
mutation were used to prime the PCR on a pET MtbDGC
plasmid DNA template. Conditions used for PCR are as follows -
in total volume of 50 mL template DNA 100 ng, thermostable
polymerase buffer (106) 5 uL, mutagenic primer 20 pmol, 0.6 mL
of 25 mM dNTPs solution and thermostable polymerase 2–5 U.
The tube was initially heated at 94uC for 2 min, followed by 19
cycles of 94uC for1 min, for annealing 54uC for 1 min and an
extension step at 72uC for 8 mins, the tube is held at 72uC for
20 mins and if required at 4uC indefinitely. Subsequently digestion
of the reaction mixture with DpnI was done to removes the
template DNA leaving intact newly synthesized double stranded
mutant PCR product designated as MtbC406S [47,48]. The
primers used in mutagenesis are listed in Table 1. The clone was
confirmed by sequencing at MWG (data not shown), Bangalore.
The plasmid MtbC406S was further transformed in BL-21
Escherichia coli cells. Protein was expressed and purified as described
in section 2.3. Activity of the mutated protein was checked as
described in section 2.5.
Circular dichorism study of MtbDGC and MtbC406S
The purified MtbDGC and MtbC406S protein after folding was
further dialyzed against the CD buffer containing 10 mM
phosphate buffer pH 8.0, 150 mM KCl and was filtered through
a 0.2 mM PVDF filter (Milipore). 5 uM of MtbDGC and
MtbC406S protein were used for CD studies. Circular dichorism
spectra were recorded on a Jasco J-715 spectopolarimeter at 22uC
using a cell of path - length 0.2 cm, bandwith 2.0 nm and a
response time of 2s. Spectra were averaged over three scans with
each sample and were recorded at a speed of 50 nm/min from
250 nm to 200 nm in a quartz cuvette.
Results and Discussion
MtbDGC possesses both DGC and PDE-A and MtbPDE
possesses PDE-A activity
Domain organization of Rv 1354c and Rv 1357c was obtained
from SMART database as shown (Figure 2A). Rv 1354c and Rv
Figure 2. Representatives of C-di-GMP specific domain architectures in Mycobacteirum tuberculosis and their subsequent protein
purification. (A) Domain architecture of the protein with GGDEF and EAL domain in Mycobacterium tuberculosis. The length of each sequence is
approximately to scale. (B) Purification of C- terminal His6 tag proteins Lane – 1 Marker, Lane - 2 MtbDGC and Lane – 3 MtbPDE. C-terminal His6 –
tagged Rv1354 is 67.6 KDa and Rv1357c is 33.9 KDa. Purity of the preparations was determined by (10%) SDS- PAGE.
doi:10.1371/journal.pone.0015072.g002
C-di-GMP in Mycobacterium tuberculosis
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MtbDGC and MtbPDE, respectively. MtbDGC and MtbPDE
were purified in soluble form as described in materials and
methods to homogeneity as judged by SDS-PAGE profile
(Figure 2B). Both the proteins were more than 80% pure (Protein
id. NP-215870.1). Further digestion of the band and subsequent
MALDI and MASCOT analysis confirmed the presence of
MtbDGC and MtbEAL proteins (data not shown). These protein
preparations were used to check the DGC and PDE-A activity.
The reaction products were separated on reverse phase High
Figure 3. MtbDGC is a bifunctional protein showing both diguanylate cyclase (DGC) and phosphodiesterae acitivity (PDE-A) and
MtbPDE is a functional protein showing phosphodiesterae acitivity (PDE-A). (A) Purified His6 protein was assayed for the ability to
synthesize c-di-GMP. HPLC analysis for the detection of c-di-GMP and pGpG: (a): GTP, (b): Purified c-di-GMP, (c): With protein MtbDGC, separated on
reversed phase HPLC. MALDI TOF analysis of the relevant HPLC fractions, in the positive ion detection mode, ions were detected at m/z of 542 (M+H)
+
for GTP, 691 (M+H)
+ and 713 (M+Na)
+ for c-di-GMP, 709 (M+H)
+ and 731 (M + Na)
+ for pGpG. (B) Purified His6 protein was assayed for the ability to
degrade c-di-GMP. HPLC analysis for the detection of pGpG. (c): Purified c-di-GMP (C): With Protein (MtbPDE),. MALDI TOF analysis of the relevant
HPLC fractions, in the positive ion detection mode, ions were detected at m/z =691 (M+H)
+ and 713 (M+Na)
+ for c-di-GMP, 709 (M+H)
+ and 731 (M +
Na)
+ for pGpG.
doi:10.1371/journal.pone.0015072.g003
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purified c-di-GMP as controls. Further, these peaks were collected
and subjected to MALDI-TOF analysis. The major ions detected
were m/z 542 (M+H)
+ for GTP, 691 (M+H)
+ and 713 (M+Na)
+ for
c-di-GMP, 709 (M+H)
+ and 731 (M + Na)
+ for pGpG, thus
confirming that MtbDGC is capable of both synthesizing and
degrading c-di-GMP (Figure 3A). Reaction mixture with
MSDGC-1 protein (Kumar and Chatterji, 2008), a known DGC
protein of Mycobacterium smegmatis was used as control. On the Thin
Layer Chromatography (TLC) plate the spot at the same Rf of c-
di-GMP apparently followed by another spot with Rf of pGpG.
Reaction mixture with MSDGC-1 was used as a positive control
and reaction mixture with cell lysate was used as the negative
control (Figure 3B).
Similarly, the reaction mixture where c-di-GMP was incubated
with MtbPDE showed reduction in peak area of c-di-GMP and
appearance of an additional peak at 16.4 min at the same
retention time of pGpG. The mass spectrum of 16.4 min peak
showed major ion at m/z 709, an addition of a water molecule to
c-di-GMP (Figure 3C). The purified pGpG showed the identical
mass spectrum at m/z 709 confirming that the MtbPDE possesses
phosphodiesterase activity.
MtbDGC is functional in vivo
Previously we reported that the MSDGC-1 which possesses
both DGC and PDE-A activities is required for long term survival
in M. smegmatis, under nutritional starvation. MtbDGC is also
bifunctional and homologous to MSDGC-1. It is intriguing to test
the in vivo functionality of MtbDGC in the MSDGC-1 disrupted
mutant DMSDGC-1. We complimented this mutant through
chromosomal integration of MtbDGC in DMSDGC-1 strain using
pMV361 integration vector containing Rv1354c gene. These
strains were grown in carbon starved conditions and their survival
was followed in terms of CFU until 20 days of incubation.
Figure 4A shows that MtbDGC was able to restore the long term
survival phenotype of the mutant strain as the CFU of wild type
and complimented strain was comparable.
Level of MtbDGC increases in stationary phase of growth
As described earlier, the level of MtbDGC in bacteria varies
according to the environmental change and the growth phase. We
determined the level of MtbDGC expression in three phases of the
growth, i.e. exponential, early stationary and late stationary phase.
Figure 4. Complementation of DMSDGC-1 with MtbDGC and its long term survival. (A) DMSDGC-1 a strain of M. smegmatis was
complemented with MtbDGC and its growth was compared with wildtype as well as DMSDGC-1. Cultures were grown in MB7H9 medium with 0.02%
v/v glucose and 0.05% Tween-80 as carbon source. Aliquots were withdrawn at different time interval after culture reached stationary phase
(48 hours of growth) and plated on MB7H9 agar supplemented with Kanamycin containing 2% w/v glucose as carbon source. The colony forming
unit were determined and plotted. (B) Level of MtbDGC increases in stationary phase. DMSDGC-1 was transformed with MtbDGC and expression was
studied in three phases of growth i.e. exponential, early stationary and late stationary phase. The a subunit (RpoA) of RNA polymerase was used as an
control because its level remains unchanged in different phases of growth. Whole cell lysates was separated on 10% SDS-PAGE and analyzed by
Western blot technique probed with antibody raised against MtbDGC.
doi:10.1371/journal.pone.0015072.g004
Figure 5. Schematic diagram of experimental setup to study
disulfide connectivity pattern.
doi:10.1371/journal.pone.0015072.g005
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SDS-PAGE and analyzed by Western blot technique with
polyclonal antibodies raised in rabbit against MtbDGC protein.
An immunoreactive protein band, approximately 68 kDa in size
(Figure 4B) was detected, with increased band intensity in the
stationary phase. Figure 4B shows that the amount of MtbDGC
was three times higher in the stationary phase culture than in the
exponential phase, as detected by quantization of the blot. In each
lane, the same amount of protein (100 mg) was loaded. It should be
mentioned here that the growth of the bacteria was found to be
slow when the dgc gene was over expressed (data not shown).
Proteolytic digestion of MtbDGC protein
The flow chart for the protein digestion is depicted in Figure 5.
Protein was digested with trypsin, chymotrypsin and in combina-
tion of both in three different sets of experiments. The ratio of
concentration of proteolytic enzyme (Trypsin and Chymotrypsin)
to protein affects the LC-ESI-MS/MS response. The optimal ESI
signal was obtained when the ratio of enzyme to protein was 1: 20.
Injection of 10–15 nmol of digested protein into the capillary of
LC-ESI-MS/MS system produced a signal sufficient to charac-
terize peptide containing labeled Cys and disulfide bonded Cys
residues (data not shown).
Figure 6. LC-ESI-MS of intact MtbDGC protein. (A) LC-ESI-MS of Histidine tagged intact MtbDGC protein and corresponding inset zoom of
deconvoluted mass m/z 68475.99 of the protein. (B) LC-ESI-MS of DTT reduced MtbDGC intact protein and corresponding inset zoom of
deconvoluted mass (m/z 68482.99). The shift in seven Dalton was observed in comparison of unreduced protein.
doi:10.1371/journal.pone.0015072.g006
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and disulfide bonds
In order to identify number of disulfide bonds and free cysteine
in the intact MtbDGC protein, LC-ESI-MS of intact protein was
studied, which confirmed m/z of 68475.99 (His6 protein). The
protein was further reduced with 8 mM DTT and mass difference
of seven Daltons m/z 68482.99 (His6 protein) was obtained
confirming the presence of at least three disulfide bonds in the
protein (Figure 6A and 6B).
A common problem in detecting peptides which contain free
cysteine residues is that the sulfhydryl group reacts with other
chemical in the solution. Thus, the cysteine residues in the protein
are alkylated by alkylting reagent like iodoacetamide, iodoacetic
acid or 4-venyl pyridiene. Here, we used iodoacetamide to alkylate
Figure 7. LC-ESI-MS of MtbDGC in reduced and oxidized condition, after digestion with chymotrypsin and trypsin. (A). LC-ESI-MS of
DTT reduced and iodoacetamide alkylated MtbDGC digested with trypsin and chymotrypsin. The singly charged ions at m/z 3796.2, 828, 833.7, 639.6,
3448.0 and 2775.0 show the mass of cysteine peptides at Cys
2, Cys
94, Cys
406, Cys
429, Cys
479 and Cys
614 respectively (B) LC-ESI-MS of unreduced and
iodoacetamide alkylated MtbDGC digested with trypsin and chymotrypsin. The singly charged ions at m/z 833.7, 1053.2 and 1399.5 [M +2H]
2+ show
the free Cys
405 residue at third position and disulfide bond at Cys
94-Cys
584 and Cys
429-Cys
614 position respectively. Corresponding insect zoom shows
the disulfide bonded Cys
2-Cys
478, the dominant ion is the doubly charged ion of [M +2H]
2+ at m/z 3566.5.
doi:10.1371/journal.pone.0015072.g007
C-di-GMP in Mycobacterium tuberculosis
PLoS ONE | www.plosone.org 9 November 2010 | Volume 5 | Issue 11 | e15072the samples, using five fold molar excess of iodoacetamide, and we
were able to detect all seven cysteine containing peptides in
proteolytic digested protein in MALDI as well as by LC-ESI-MS
analysis. A sample that displayed an isotopic distribution of the
required peptides was further used for the studies. Figure 7(A) shows
a representative mass spectrum from DTT (200-fold molar excess)
reduced and iodoacetamide labeled protein after digestion with a
combination of trypsin and chymotrypsin. Ions at m/z 3796.2 (aa.
1–35), 828 (aa. 92–98), 833.9 (aa. 400–407), 693.6 (aa. 428–432),
3448.8 (aa. 461–494), 341.3 (aa. 584–585) and 1452.6 (aa 610–623)
represents Cys
2, Cys
94,C y s
406, Cys
429, Cys
479 containing peptides,
respectively, matching with the calculated value as depicted in
table 2. Figure 7(A) was compared with mass spectrum depicted in
Figure 7(B) generated by iodoacetamide labeled, oxidized protein
after double digestion with trypsin and chymotrypsin. Singly
charged [M + H]
+ 833.7, 1053.2 and doubly charged [M +2H]
2+
3566.5 and 1399.5 ions corresponds to the calculated mass of free
cysteine peptide Cys
406 and disulfide connected dipeptide Cys
94-
Cys
584, Cys
2-Cys
479 and Cys
429-Cys
614, respectively, as depicted in
table3.Each fragmentthatcontained iodoacetamidelabeled Cys
406
residue showed a mass shift of 57 Da (Mass of iodoacetamide)
compared with the mass of unlabelled peptide.
To evaluate and confirm the pattern obtained from trypsin and
chymotrypisn treated double digested protein, MtbDGC protein
was also digested with chymotrypsin or trypsin. The m/z 4242.7
(aa. 1–39), 1313 (aa. 92–112), 1453.0 (aa. 395–407), 1164.0 (aa.
424–432), 5399.0 (aa. 461–513), 2648.9 (aa. 562–590) and (His6)
3385.2 (aa. 594–629) ions are in good agreement with the
calculated mass of free cysteine containing peptide labeled with
iodoacetamide (Table 2) when digested with Chymotrypsin (data
not shown). The predicted disulfide linked peptides Cys
429-Cys
614,
Cys
94-Cys
584 and Cys
2-Cys
479 were also detected in chymotrypsin
digested and reduced protein. The m/z for 3176.9 [M +3H]
3+,
3846.2, 4491.6 [M + H]
H+ (table 3) ions represents dipeptide
linked Cys
2-Cys
479, Cys
94-Cys
584 and Cys
429-Cys
614 respectively.
The m/z 1453.0 for the [M + H]
+ ion shows free cysteine at
Cys
406. Similar results were also obtained with trypsin digested
protein (data not shown).
Disulfide connectivity
Disulfide connected dipeptide were analyzed by LC-ESI-MS/
MS and individual peptides were identified based on the
information obtained by tandem mass spectra. The technique
involves the breakage of peptide backbone generating predomi-
nantly b and y-type ions [49]. The LC-ESI-MS/MS has been
shown to give ambiguous result due to thiol exchange reaction. To
overcome this problem all the analysis was done in the presence of
alkylting agent iodoacetamide. To prove that the disulfide bonding
is not altered, alkylation was done before or after protein was
proteolyticaly digested.
MS/MS analysis of singly charged [M + H]
+ ions at m/z 776.6
(aa. 400–407) obtained from trypsin and chymotrypsin digested
Table 2. Theoretically and experimental mass of peptides generated from reduced, alkylated and digested samples of MtbDGC.
Position of Cysteine in Protein
Expected Mass
(m/z)
Observed Mass
(m/z)
Unlabelled Labeled Unlabelled Labeled
Digested by Trypsin + Chymotrypsin
Cys
2 (aa- 1-35) 3739.2 3796.2 3739.2 3796.2
Cys
94 (aa-92-98) 770.9 827.9 770.9 828.9
Cys
406 (aa-400-407) 776.9 833.9 776.9 833.7
Cys
429 (aa-428-432) 582.6 639.6 582.6 639.6
Cys
479 (aa-461-494) 3391.8 3449.8 3391.8 3448.0
Cys
584 (aa-584-586) 284.3 341.3 284.3 341.3
Cys
614 (aa-610-629) 2218.51 2275.51 2218.0 2275.0
Digested by Chymotrypsin
Cys
2 (aa-1-39) 4185.7 4242.7 4185.7 4242.0
Cys
94 (aa-92-112) 1257.4 1313.4 1256.0 1313.4
Cys
406 (aa-395-407) 1396.6 1453.4 1396.0 1453.0
Cys
429 (aa-424-432) 1107.3 1164.3 1107.3 1164.0
Cys
479 (aa-461-513) 5342.0 5399.0 5342.0 5399.0
Cys
584 (aa-562-590) 2591.9 2648.9 2591.9 2648.6
Cys
614 (aa-594-629) 4151.8 4208.8 4151.8 4208.0
Digested by Trypsin
Cys
2 (aa-1-35) 3739.2 3796.1 3739.6 3796.6
Cys
94 (aa-81-98) 2023.3 2080.3 2025.1 2097.8
Cys
406 (aa-400-422) 2355.7 2412.7 2353.0 2410.0
Cys
429 (aa-423-427) 2204.4 2261.4 2201.0 2258.0
Cys
479 (aa-448-494) 4997.5 5054.5 4998.0 5559.0
Cys
584 (aa-584-586) 440.5 497.52 441.2 498.2
Cys
614 (aa-610-629) 2218.5 2275.5 2218.5 2275.5
doi:10.1371/journal.pone.0015072.t002
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406 as a free cysteine
containing peptide, Figure 8A. The Collision induced dissociation
(CID) spectrum of the linearized peptide showed successive b and
y-ions of m/z 284.7 (b3), 355 (b4), 451.3 (b5), 508.3 (b6), 611.4
(b7), 324.7(y3), 421 (y4), 492 (y5) and 718.7 (y7). The mass
difference between the successive b or y ions represented the
residual mass of amino acid as obtained by theoretical digestion.
More than 50% of the predicted amino acid sequence obtained by
MS/MS of the peptide matched with Mascot search data base.
Figure 8B represents the free Cys
406 peptide ion m/z 833.7
obtained from chymotrypsin and trypsin digested and iodoaceta-
mide labeled protein in unreduced condition. The mass differences
between the successive b or y ions are in agreement with the
calculated mass. To further confirm that Cys
406 is free in
MtbDGC protein was digested with chymotrypsin in oxidized
condition and was analyzed by LC/ESI/MS-MS. Singly charged
[M +H]
+ ion at m/z 1396.0 confirmed peptide containing Cys
406.
MS/MS of unreduced, trypsin digested and iodoacetamide labeled
sample also confirmed Cys
406 to be a peptide containing free
cysteine (Figure 8C). Spectra were also acquired to locate free
cysteine in reduced condition for trypsin and Chymotrypsin
digested protein (data not shown).
MS/MS analysis of the doubly charged [M +2H]
2+ ion at m/z
3566.5, obtained from chymotryptic and tryptic digested sample,
alkylated with iodoacetamide, confirmed that the peptide
containing Cys
2 (m/z 3739.2) was linked to the peptide containing
Cys
479 (m/z 3391.8) (Figure 9A). The CID spectrum of dipeptide
containing Cys
2 and Cys
479 showed successive b and y type ions of
m/z 389.1 (Y3), 483.4 (y4), 617.7 (Y5), 689.2 (y6), 877.0 (y8, b9),
1137.4 (y10), 1937.2 (b16), 2092.0 (Y20), 2352.6 (b23), 2904.0
(Y27), 3044.2 (b29), 3274 (y26) and 3389.6 (Y32). Evidence was
also obtained for another expected disulfide pair (Cys
94-Cys
584). As
shown in Figure 9B, the MS/MS of singly charged ion at m/z
1053.2 confirms that peptide containing Cys
94 (m/z 770) is linked
with peptide containing Cys
584 (m/z 284.3). The CID spectrum
showed successive b and y type ions of m/z 288.8 (B3), 293 (Y2),
407.2 (Y3), 308 (b3), 409 (b4), 722.2 (b7), 894 (b9), 288.8 (y3), 385
(y4), 500 (y5), 600.5 (y6), 672.2 (y7), 769 (y8) and 882 (y9). As
shown in Figure 9C, the tandem mass spectra obtained from the
ion m/z 1976.8 confirm the structure of peptide containing the
third disulfide bridge between Cys
429-Cys
614. Figure 9C shows
that the prominent fragments are derived from the singly charged
ion of dipeptide containing Cys
429 and Cys
614. From MS/MS
analysis it can be seen that only minor fragmentation occurred
within the amino acid sequence between disulfide linked cysteine
residues. The data showed no other disulfide linked peptides, other
than the expected. It is consistent with the fact that it is difficult to
cleave peptides that contain –S-S- bonds as fragmentation requires
cleavage of double bonds [28]. No evidence was found for the
fragmentation of the amide bonds and formation of linearized
sequences by cleavage of peptide bonds inside the disulfide ring [50].
Similar dissociation fragmentation processes have already been
reported earlier for intramolecular disulfide-bonded peptides [26].
The obtained data confirmed the disulfide connectivity within
intramolecular disulfide bond, but not intermolecular disulfide
bond. Similar results to those shown in Figure 9(A–C) were
Table 3. Theoretically and experimental mass of peptides generated from intact proteins samples of MtbDGC upon oxidation.
Position of Cysteine in Protein
Expected Mass
(m/z)
Observed Mass
(m/z)
Unlabelled Labeled Unlabelled Labeled
Digested by Trypsin + Chymotrypsin
(Cys
2 -C y s
479) 7129.0
[(3739.2+3391.8) -2=7129.0]
7129.0 [M+2H]
2+: 3566.5 [M+2H]
2+: 3566.5
(Cys
94 -C y s
584) 1053.2
[(770.9+284.3) -2=1053.2]
1053.2 [M+H]
+: 1053.2 [M+H]
+: 1053.2
Cys
406 776.9 833.9 [M+H]
+
776.9
[M+H]
+: 833.7
(Cys
429-C y s
614) 2799.1
[(582.6+2218.5) -2=2799.1]
2856.1 [M+H]
+: 2799.1 [M+H]
+: 2856.0
Digested by Chymotrypsin
(Cys
2 -C y s
479) 9525.7
[(4185.7+5342) – 2=9525.7]
9525.7 [M+3H]
3+
3176.9
[M+3H]
3+
3177.9
(Cys
94 -C y s
584) 3847.9
[(1257.4+2591.9) – 2=3847.9]
3847.9 [M+H]
+: 3846.2 [M+H]
+: 3846.2
Cys
406 1396.6 1453.6 [M+H]
+
1396.0
[M+H]
+: 1453.4
(Cys
429-C y s
614) 5259.1
[(1107.3+4151.8) – 2=4434.2]
5316.1 [M+H]
+
2629.5
[M+H]
+: 2629.5
Digested by Trypsin
(Cys
2 -C y s
479) 9145.0
[(3739.2+4997.7) – 2=8734.7]
8791.7 [M+3H]
3+: 2911.5 [M+3H]
3+: 2911.5
(Cys
94 -C y s
584) 244384.0
[(2202+2184) – 2=4384.0]
4384.0 [M+2H]
2+: 2461.4 [M+2H]
2+
2461.4
Cys
406 2355.7 2412.7 2353.0 2410.0
(Cys
429-C y s
614) 4420.9
[(2204.4+2218.5) – 2=4420.9]
4477.9 [M+H]
+:
4420.9
[M+H]
+
4477.9
doi:10.1371/journal.pone.0015072.t003
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PLoS ONE | www.plosone.org 11 November 2010 | Volume 5 | Issue 11 | e15072Figure 8. LC-ESI-MS/MS of peptide containing free Cysteine406. (A). LC-ESI-MS/MS of m/z 776.6, containing free Cys
406 from DTT treated,
trypsin and chymotrypsin digested MtbDGC. Inset shows the sequence derived from this MS/MS spectrum. (B) LC-ESI-MS/MS of m/z 833.7, containing
freeCys
406fromunreducedtrypsinandchymotrypsindigestedMtbDGC.InsetshowsthesequencederivedfromthisMS/MSspectrum.(C)LC-ESI-MS/MS
of m/z 1396, containing free Cys
406 from DTT treated, chymotrypsin digested MtbDGC. Inset shows the sequence derived from this MS/MS spectrum.
doi:10.1371/journal.pone.0015072.g008
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PLoS ONE | www.plosone.org 13 November 2010 | Volume 5 | Issue 11 | e15072Figure 10. Modeled MtbDGC. (A) Distribution of seven cysteines on full length MtbDGC. (B) Modeled MtbDGC with the disulfide bonds. (a)
Modeled protein with exposed Cys406 residue. GGDEF motif (residue number 261–265) and is shown in black color. (b) Disulfide bond between Cys
residue Cys2-Cys479 (c) Disulfide bond between Cys residue 894-584. (d) free and exposed Cys406 (e) disulfide between Cys residue 429-614.
doi:10.1371/journal.pone.0015072.g010
Figure 9. LC-ESI-MS/MS of disulfide connected dipeptide. (A) LC-ESI-MS/MS m/z 3566.5 (doubly charge), containing disulfide bonded Cys
2-
Cys
479 peptide from trypsin and chymotrypsin digested MtbDGC. Inset shows the sequence derived from this MS/MS spectrum. (B) LC-ESI-MS/MS of
m/z 1053.2, containing disulfide bonded Cys
94-Cys
584 peptide from trypsin and chymotrypsin digested intact unreduced MtbDGC. Inset shows the
sequence derived from this MS/MS spectrum. (C) LC-ESI-MS/MS of m/z 2799.1, containing disulfide bonded Cys
429-Cys
614 peptide from trypsin and
chymotrypsin digested MtbDGC. Inset shows the sequence derived from this MS/MS spectrum.
doi:10.1371/journal.pone.0015072.g009
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with or without iodoacetamide.
Sequence alignment of proteins containing GAF, GGDEF,
EAL domains and homology modeling of Rv1354c
There is no structure available for full length GAF-GGDEF-EAL
bifunctional protein. However, to probe the disulfide connectivity, even
an approximate structure would be very useful. Structure obtained by
modeling studies (Figure 10) showed a good correspondence between
the predicted disulfide connectivityo b t a i n e db ym a s ss p e c t r a la n a l y s i s .
Schmidt and coworkers [51] first noticed that the catalytically
active EAL domains seem to contain a conserved motif that was
later confirmed to contain loop 6 [DFG(T/A)GYSS], loop
between the a6-helix and b6-strand and one of the residues
(Asp) for Mg
2+ binding [51,52]. Alignment of the EAL domain
sequences shows a conserved motif [DFG(A/S/T)(A/G)(Y/F)(S/
T)(S/T/G/A/N)] or also called loop 6 (Figure S1), apart from
conserved EAL motif and many conserved acidic residues. Similar
result was found when EAL domain (PF00563) family (total of
8082 sequences) in PFAM database, was analyzed (data not
shown). Out of three domains named as GAF (residue 28–171),
GGDEF (residue 212–345) and EAL (residue 354–609), EAL
domain is the biggest with (b/a)10 barrel fold with 10 a-helix and
b-strands each assigned by STRIDE [53]. Percentage consensus of
G
2,G
4,F
3,S
7 and S
8 in the loop 6 was found to be 88%, 79%,
80%, 65% and 61% respectively highlighting the importance of
both Glycine residues along with Phenylalanine in the loop. Above
result is based on the alignment of 8082 sequences belonging to
EAL domain family. G
514 and G
516 are involved in the side chain -
main chain hydrogen bonding with E
484, while F
513 and D
534
residues are involved in the main chain-main chain hydrogen
bonding (Figure 11) [54]. Hence, it can be concluded that the
above three residues are important for the positioning of the loop
6. Depending upon the involvement of residues of loop 6 in
forming hydrogen bond, they can be divided into two parts: i)
D
512F
513G
514T
515G
516 (ii) Y
517S
518A
519. The first half gives
stability and proper positioning to the loop, while the latter half
is flexible. Alignment of EAL domain sequences obtained from the
GAF, GGDEF, EAL architecture shows very high conservancy of
P
376,E
484,G
505, L
523,K
532,E
568,G
569,V
570,E
571,Q
588G
589.A s
discussed earlier E
484 is involved in the hydrogen bonding with
two glycines of loop 6. On mapping P
376,K
532,E
568,G
569,E
571,
Q
588,G
589 on the modeled structure, it was found that these
residues are in close proximity with E
389A
390 L
391 motif (Figure 12)
may also play an important role in coordinating with Mg
2+ions.
GGDEF domain sequences were also aligned in the same
fashion as the EAL domain sequences and were found to have
high conservancy of G
232,D
237,G
307 &R
259 apart from
GGDEF
261–265 motif (Figure S2). When the above three residues
were mapped on the structure, D
237 is found to be on the surface,
possibly making it important in oligomerization. High conservancy
of G232 can be related with the need of neglecting satiric clashes
and the proper orientation of the two consecutive helices. R
259
may help in the stabilizing the GTP-GGDEF domain complex as
it is close to the GGDEF motif.
P
131 &G
140 of GAF domain shows high conservancy (Figure
S3). Both of them are part of beta strands and at the same time
they are involved in van der Waals interaction with R
381 and N
54
respectively.
Although the part of linker region between GAF and GGDEF
domain (linker 1; residue 184–211) is considered as a part of
GGDEF domain, yet while analyzing it was considered as a part of
linker region (according to SWISSPROT linker 1 ranges from
residue 172–211) and analysis shows the high conservancy of D
187,
T
190 &N
194,R
195(Figure S4). All are polar residues and may play
important role in stabilizing the oligomer of the proteins.
Several N-terminal residues (residue 1–28) are involved in either
main chain-main chain (M
1-V
565, C2-V
565,R
583-D
4,A
6-D
581)o r
side chain-main chain (T
7-T
165,Q
9-A
159) interaction with the
residues of GAF and EAL domain. At the same time C
2 forms a
disulfide bond with C
479, showing the importance of the N-
terminal residues in stabilizing the GAF-EAL interface. Although
C-terminal residues are not involved in the formation of hydrogen
bond, C
614 forms a disulfide bond with C
429. Hydrogen bonds
were found between the GAF and EAL domain residues also (data
not shown). Interestingly enough GAF domain does not interact
with the GGDEF domain, but interactions were found between
the linker 1(residue 172–211).
EAL-GGDEF interface has lesser number of interactions
compared to that of the GAF-EAL interface. Few main chain-
main chain & side chain-main chain hydrogen bonds were found
(data not shown).
Figure 11. Part of EAL domain with the residues of loop 6.
Hydrogen bond between residues is shown in the black broken line.
doi:10.1371/journal.pone.0015072.g011
Figure 12. EAL motif shown in yellow color and the conserved
residues in close proximity to the motif is highlighted.
doi:10.1371/journal.pone.0015072.g012
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using CONTACT program of CCP4 program suit by setting the
limit of distance below 4.5 A ˚ [55]. The result shows that although
EAL is the last domain, yet it is in contact with both GAF and
GGDEF domains.
The proposed structure of Rv 1354c protein shows well exposed
GGDEF motif. Disulfide bond length was found to be 2.3 Au
(Cys
2-Cys
479, Cys
429-Cys
614) and 2.2 Au (Cys
94-Cys
584). Cys
406
residue of EAL domain is more solvent assessible than other six
cysteine residues.
Figure 13. Functional activity of MtbC406S mutated protein. (A) LC-ESI-MS of DTT reduced MtbC406S digested with trypsin and
chymotrypsin. Them/z 760.9 shows the substitution of Cys
406 to Serine
406. (B) (a) MtbC406S protein: MALDI TOF analysis, in the positive ion detection mode.
No peaks are obtained at 691 (M+H)
+ and 713 (M+Na)
+ for c-di-GMP, 709 (M+H)
+ and 731 (M + Na)
+ for pGpG (b) MtbDGC protein for control: MALDI TOF
analysis, in the positive ion detection mode, ions were detected at 691 (M+H)
+ and 713 (M+Na)
+ for c-di-GMP (c) 709 (M+H)
+ and 731 (M + Na)
+ for pGpG.
doi:10.1371/journal.pone.0015072.g013
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mutagenesis
From the Mass spectral data it was confirmed that cysteine at
position three (Cys
406) is free. To further elucidate whether Cys
406
has any role in the enzymatic activity of the protein, the Cys
406
was mutated to serine. Cysteine mutation was confirmed by LC-
MS and the mutated protein showed the mass of 68459.93 Da
(histidine tagged) (data not shown). MtbC406S was further
reduced with 8 mM of DTT and the reduced protein showed
the mass difference of seven Da confirming the presence of only
three cysteine bond and Cys
3 (Cys
406) is free (data not shown). The
chymotrypin and trypsin digested MtbC406S shows the change of
16 Da in the peptide bearing cysteine at position three confirming
the mutation of Cys
406 to Serine
406 (aa. 400–407) (Figure 13A).
MS/MS analysis of mutated peptide (aa. 400–407) obtained from
trypsin and chymotrypsin digested protein showed the mutation of
cysteine to serine (data not shown). In order to check the activity of
c-di-GMP in MtbC406S protein, the mass spectrometric as well as
thin layer chromatographic analysis were done as shown in
Figure 13B and Figure 13C. It is clear from the data that Cys
406
which is a free cysteine plays a critical role in the regulation of
enzymatic activity and by mutating cysteine to serine, protein
activity is lost. However, when CD spectrum of the mutated protein
was compared with MtbDGC protein (Figure 14) and no difference
was found in the folding pattern of the protein. This indicates that
Cys
406 plays an important role in c-di-GMP regulation but does not
play any significant role in the folding of the protein.
Concluding remarks
The cyclic dinucleotide 39,5 9 cyclic guanylic acid (c-di-GMP)
has been characterized as an important second messenger that
affects a range of physiological traits in bacterial species. Many
reports have come in recent past, from diverse branches of
bacteria utilizing c-di-GMP signaling pathways [56,57]. Prior to
our study in Mycobacterium smegmatis (Kumar and Chatterji, 2008),
nothing was known about the role of c-di-GMP in Mycobacteria.
We reported that MSDGC-1 protein is a bifunctional protein and
can synthesize and degrade c-di-GMP in vitro. This study was
undertaken to follow the role of C-di-GMP in M. tuberculosis. In this
work we investigate the homologue of MSDGC-1, MtbDGC in M.
tuberculosis H37Rv. We reveal the following findings: (1). M.
tuberculosis has one protein with GAF-GGDEF-EAL (MtbDGC)
and another with only EAL domain (MtbPDE). (2). MtbDGC is a
bifunctional multidomain protein exhibiting both the activity of
DGC and PDE-A. (3). MtbPDE is a single EAL protein exhibiting
only PDE-A activity. (4) Presence of three disulfide bond and one
free cysteine in MtbDGC protein. (5) Upon mutation of free
cysteine at position 406 to serine, synthesis of C-di-GMP was
completely abolished.
All the known examples of GGDEF-EAL domain either have
DGC or PDE-A activity. However, it is difficult to predict the
dominant activity from the primary sequence [56,58]. In
Rhodobacter sphaeroides and Vibrio parahaemolyticuss GGDEF/EAL
protein shows both DGC and PDE-A activities as a function of
environmental cue [59,60], but no clear cut distinction of the
activities were possible. In this regard mycobacterial protein
(MSDGC-1 and MtbDGC) is the first such protein which shows
two activities at a time in vitro. It appears that both M. tuberculosis
and M. smegmatis proteins have similar function; the role of
additional EAL domain protein in M. tuberculosis is yet to be
addressed.
M. tuberculosis DGC protein reported here was found to be
predominantly expressed at the stationary phase suggesting its role
in survival at stationary phase. This hypothesis was substantiated
by complementation of MSDGC-1 knockout strain of M. smegmatis
by mtbdgc. From sequence analysis and presence of dual activities
it appears that both M. smegmatis and M. tuberculosis DGC will have
similar function in the respective host. However, the only
difference is presence of seven cysteines in MtbDGC. Comparison
of the sequences of DGC protein revealed that three cysteines are
conserved in MSDGC-1 out of seven in MtbDGC. It is interesting
to study the presence of high numbers of cysteines in MtbDGC
with regards to folding and regulation of c-di-GMP signaling at
enzymatic level.
In order to address above hypothesis we studied disulfide
bonded cysteine and free cysteine in MtbDGC. Disulfide bonded
cysteine might play and crucial role in folding of MtbDGC,
whereas free cysteine may be involved in regulation activity of
enzyme. Extensive mass spectrometric analysis confirmed the
presence of three disulfide bonded Cys
94-Cys
584, Cys
2-Cys
479 and
Cys
428-Cys
614 and one free cysteine at position Cys
406. Data
obtained from mass spectrometric analysis was further confirmed
by homology modeling.
Structure obtained by homology modeling revealed presence of
three disulfide bonds and one free cysteine with exposed GGDEF
motif. The homology model presented here, is the first example
which shows that the last (EAL) domain comes in the middle
interacting with the other two (GAF & GGDEF) domains.
Probably it may hint in the possible mechanism regulating the
activities of such proteins having both GGDEF & EAL domains to
avoid a possible futile cycle. Apart from conserved motifs and
polar residues, significant number of conserved Glycine residues
was also found. Almost all conserved residues are either involved
in the van der Waals interaction or in the hydrogen-bonding and
are important in maintaining the orientation of the domains and
thereby the shape of the protein.
Cys406 was found to be distinct far from the remaining six
cysteines and does not participate in any disulfide connectivity. As
we hypothesized that free cysteine might have regulatory role. We
mutated Cys
406 to Serine and enzymatic activity was assayed. C-
di-GMP synthesis activity was completely abolished in mutated
protein. The exact role of Cys
406 in mechanism of c-di-GMP
synthesis still remains to be investigated. To our best knowledge
this is the first example of regulation of enzymatic activity by free
cysteine in GAF-GGDEF-EAL protein.
Figure 14. Circular Dichorism spectra of MtbDGC and MtbC406S.
doi:10.1371/journal.pone.0015072.g014
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Figure S1 Alignment of EAL domain from the protein
having GAF, GGDEF, EAL architecture. Protein of our
interest is highlighted and [DFG(A/S/T)(A/G)(Y/F)(S/T)(S/T/
G/A/N)] motif is shown in the box. Protein of interest contains
DFGTGYSA motif.
(TIF)
Figure S2 Alignment of GGDEF domain from the
protein having GAF, GGDEF, EAL architecture. Protein
of our interest is highlighted and G232, D
237,G
307,R
259 &
GGDEF
261-265 motif is shown in box. Residue number of residues
corresponds to the number in the protein chosen.
(TIF)
Figure S3 Alignment of GAF domain from the protein
having GAF, GGDEF, EAL architecture. Protein of our
interest is highlighted and P
131 &G
140 are boxed.
(TIF)
Figure S4 Alignment of GGDEF domain from the
protein having GAF, GGDEF, EAL architecture. Protein
of our interest is highlighted and D
187,T
190 &N
194R
195 are shown
in box.
(TIF)
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